HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Solicits Protocol For Assessing Cosmetic Ingredient Aggregate Exposure Risks

Executive Summary

According to its May 16 notice, the agency intends to award the contract to NSF International. An FDA spokesperson said NSF already undertook related work for the agency in 2018 and has rendered similar services for the US Environmental Protection Agency.

Advertisement

Related Content

FDA Contracts For QRA Model To Determine Safe Use Levels For 26 Fragrance Allergens
National Standard For Cosmetics Quality Nearing Finish Line With Retailer Buy-In
NSF's Cosmetics Verification Program Fizzles, While EWG's Could See Second Boom

Topics

Advertisement
UsernamePublicRestriction

Register

RS148886

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel